Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Sep 1;33(3):329-332.
doi: 10.53854/liim-3303-10. eCollection 2025.

A destruent case of recurrent primary naso-pharyngeal tuberculosis in a migrant

Affiliations
Case Reports

A destruent case of recurrent primary naso-pharyngeal tuberculosis in a migrant

Andrea Sergio Sarassi et al. Infez Med. .

Abstract

A 24-year-old Ukrainian man with post-natal developmental disability was treated for presumptive facial cutaneous TB in 2018 in his home country. After moving to Italy, his nostril lesion recurred in 2021, expanding to the upper lip, but he was lost to follow-up before a diagnosis was made. In 2023, when symptoms worsened, a biopsy was performed showing chronic inflammation and negative microbiological molecular tests and culture. By 2024, the lesion spread to the eyelids with worsening ulcerations. After surgical resection, histology revealed a vegetative, haemorrhagic mucosa with necrotic granulomatous inflammation and rifampin-susceptible Mycobacterium tuberculosis (Mtb) was detected at molecular testing. Diagnosis of recurrent primary cutaneous TB without pulmonary involvement was made and treatment for drug susceptible TB was initiated, leading to complete remission of the facial lesions. Primary cutaneous TB without pulmonary involvement is rare, presenting as nodules, plaques, papules, or ulcers. Diagnosis requires systemic evaluation, imaging, infection screening and expert consultation. Cutaneous TB (CTB) is uncommon in Ukraine and accounts for less than 2% of extrapulmonary TB cases with frequent association with immunosuppression and delayed presentation. Although infrequent, CTB mirrors the wider TB scenario, that is also characterized by MDR-TB in 27% of new and 45% of retreatment cases, and XDR-TB in 13% of MDR-TB cases. In individuals coming from TB endemic areas with strong clinical suspicion, empirical TB diagnosis should always be considered despite negative microbiology to enable timely treatment and prevent progression. A multidisciplinary approach is essential for accurate diagnosis and optimal management.

Keywords: : primary cutaneous tuberculosis; TB; endemic countries; recurrent skin lesions.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Panel A: nasal tip was deformed from atrophic and retracting scars, as result of recurrent ulcerative-exudative phenomena. Moreover, the upper lip was disrupted, being enlarged, and thinner, with intact skin, except for the labiogenial margins, showing ulcerative-exudative lesions with serous-crusted material. Similar structural alteration was observed in the homolateral upper and lower eyelids, appearing replaced by inflammatory tissue, with a mamillated and exudative appearance. Panel B: clinical presentation after 9 months of antitubercolar treatment ( 2 months HRZE, 7 months HR).

References

    1. Kovalchuk A, Yukhymenko N, Savchuk O. Clinical and epidemiological characteristics of extrapulmonary tuberculosis in Ukraine. Tuberk Lung Dis. 2021;99(4):24–29.
    1. Barbagallo J, Tager P, Ingleton R, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol. 2002;3(5):319–328. - PubMed
    1. Bravo FG, Gotuzzo E. Cutaneous tuberculosis. Clin Dermatol. 2018;36(4):491–498. - PubMed
    1. Misirovs R, Johnston L, Green R. Primary nasopharyngeal tuberculosis. BMJ Case Rep. 2022;15(12):e251927. - PMC - PubMed
    1. Santos JB, Figueiredo AR, Ferraz CES, et al. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I. An Bras Dermatol. 2020;95(5):564–578. - PMC - PubMed

Publication types

LinkOut - more resources